Global Canine Influenza Vaccine Market is expected to grow with a CAGR of 5.2% over the forecast period.
Global Canine Influenza Vaccine Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028- Increasing prevalence of canine influenza infections, rising technological advancements, and growing awareness about canine vaccinations are major factors anticipated to drive the growth of the Global Canine Influenza Market.
Canine influenza also called as dog flu. This sort of influenza is brought about by various influenza viruses A, out of which, the most often infected virus is the equine influenza infection H3N8. It spreads through vapour sprayers or droplets sneezing, coughing, and barking. It happens when a healthy canine comes in close contact with infected ones. Some of the time, it spreads by implication through individuals or articles that have recently interacted with an infected canine. The virus is also transmitted by via contaminated objects such as food and water bowls, collars, leashes, toys, bedding, and through nose-to-nose contact between dogs. Canine influenza is a serious infection rather than the average respiratory infection. The vaccine against canine influenza is the best preventive measure against the canine influenza vaccine. In June 2009 first canine influenza vaccine was launched. The aim of the vaccination is to control the spread of the canine influenza disease.
The Covid-19 pandemic has also impacted the growth of the global canine influenza vaccine market. Due to the lockdown conditions and restrictions on transportation impacted the canine influenza vaccine production and supply chain disruptions. During Covid-19 pandemic, focus of healthcare industry has shifted on research and development of Covid-19 vaccine. Also, the dogs’ vaccinations programmes were postponed due to seriousness of Covid-19.
The global canine influenza vaccine market is segmented into on the basis of type, application, and region & country level. On the basis of type, the global canine influenza vaccine market is segmented into liquid and powder. Based upon application, the global canine influenza vaccine market is segmented into homes, pet clinics and others.
On January 31st, 2017; University of Rochester School of Medicine and Dentistry produced new flu strains that could infect people. Two influenza A virus subtypes have been reported in dogs in the last 16 years the canine influenza virus (CIV) H3N8 and H3N2 of equine and avian origin, respectively.
On October 7th, 2016; Merk Animal Health U.S Department of Agriculture USDA had announced approval of canine flu bivalent vaccine which is that the first vaccine to supply protection against both strains of canine influenza that against both canine influenza virus (CIV) H3N2 and canine influenza virus H3N8. CIV H3N2 was identified last year within the us following multiple outbreaks throughout the country. Nobivac Canine Flu Bivalent is suggested for healthy dogs 7 weeks aged or older as an aid within the control of disease related to canine influenza virus H3N8 and canine influenza virus H3N2.
One of the major factors driving the growth of the canine influenza vaccines market is increasing prevalence of canine influenza infections. The canine influenza is highly transmissible disease which has been transmitted worldwide and now it is major health concern for all dog lovers. The virus of canine influenza spreads rapidly and may cause serious disease to dogs, such as pneumonia if the treatment got delayed. For example; according to the American Veterinary Medical Association (AVMA); there are about of 800 confirmed and associated cases with CIV H3N2 reported in LA County and 7 canines have passed on from the disease.
In addition, rising number of technological advancements in this field are also supplementing the market growth. For instance; as per the news published on January 28th, 2017, department of Microbiology and Immunology Luis Martinez-Sobrido created two vaccines to protect against H3N8 canine influenza virus, which is currently circulating in dogs in the United States. The H3N8 vaccine was made using genetically modified viruses.
Moreover, growing awareness regarding the benefits of canine influenza vaccines also drives the global canine influenza vaccines market. Vaccinations of dog vaccinations are the harmless and most cost-effective way to protect dog from infectious preventable diseases. Canine influenza vaccines are given to the day care going dogs and boarding, the groomers or any place which is crowded by other dogs where they will be among other dogs. Hence, increasing awareness about vaccinations drives the market growth.
However, high cost required for canine influenza vaccine development may hamper the growth of the global canine influenza vaccine market. In spite of that, ongoing research and development in vaccines can provide various opportunities for the further growth of the global canine influenza vaccine market.
North America is expected to dominate the global canine influenza vaccines market due to outbreak of canine influenza, rising pet adoption and highly developed healthcare infrastructure in this region. For instance; as per Fox News from July 2021 to October 2021, approximately 800 dogs have been infected with canine influenza in Los Angeles. In addition, rising pet adoption will also supplement the market growth as increased pet number will increase the vaccination drive. For instance, American Pet Products Association (APPA), 1.9 million pets were adopted by Americans adopted in 2020. Moreover, highly developed infrastructure in North America will provide research opportunities in canine influenza vaccines which also expected to acerate the growth of the global canine influenza vaccines.
Asia Pacific is expected to witness a fastest growth in the global canine influenza due to occurrence of new strains of canine influenza virus. For instance; as per Canine Journal vaccines, in June 2018 a new strain was detected (H1N1) in dogs in China.
|Historical data||2015 - 2020|
|Forecast Period||2021 - 2028|
|Market Size in 2021:||USD XX Million|
|Base year considered||2020|
|Forecast Period CAGR %:||
|Market Size Expected in 2028:||USD XX Million|
|Tables, Charts & Figures:||175|
|Canine Influenza Vaccine Companies||Intervet Inc, Zoetis Services LLC, CSL Limited, Covetrus, Merck Animal Health, others|
|Segments Covered||By Type, By Application|
|Regional Analysis||North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa|